Martin Samuels, a Harvard University medical professor, has started a new company that will provide continuing medical education that is different from many of the existing programs in that it will not be subsidized by the pharmaceutical industry, The Boston Globe reported. The influence of drug company money on programs in which medical professionals learn about new treatments has been widely criticized, but some have noted the lack of programs that are totally free of the pharmaceutical cash. The new business will get its revenue directly from universities, hospitals and other organizations that want to provide continuing medical education -- and will not take any money from the drug industry.
Inside Higher Ed’s Blog U
What Others Are Reading